SCHEDULE: Investor's Strata Medical Warrants Expire Worthless

Velibor Krstic's 1.58 million Strata Critical Medical warrants expired worthless, reducing beneficial ownership to zero.

Summary

• Velibor Krstic's 1,577,500 warrants to purchase Class A Common Stock of Strata Critical Medical, Inc. expired worthless on May 7, 2026.
• The expiration occurred in accordance with the terms of the Warrant Agreement dated September 12, 2019.
• As a result, the reporting person ceased to be a beneficial owner of more than five percent of the class of securities.
• This filing serves as the final amendment to the Schedule 13D for these securities.
• The warrants were originally purchased using personal funds.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative event for the reporting investor, as their warrants expired worthless, indicating a complete loss on that specific investment. It provides no positive indicators for the company itself.

Negatives

• Velibor Krstic's 1,577,500 warrants expired worthless, resulting in a complete loss of the investment in these warrants.
• The expiration at $0.00 indicates the warrants were out-of-the-money or the underlying stock price did not reach the exercise price by the expiration date.

Risks

• The risk of warrants expiring worthless if the underlying stock price does not perform as expected or if the exercise price is not met by the expiration date.

Future Outlook

This filing reports a past event of warrant expiration and does not contain any forward-looking statements or guidance regarding Strata Critical Medical, Inc.'s future performance or the reporting person's future investment intentions.

Industry Context

StockSavvy.ai notes that the expiration of a significant block of warrants held by an individual investor, while specific to that investor, can sometimes reflect broader market sentiment or the performance trajectory of the underlying company's stock leading up to the expiration date. However, this filing provides no direct insight into Strata Critical Medical, Inc.'s operational or financial health, focusing solely on the investor's ownership change.

Stakeholder Impact

• Shareholders: No direct impact on existing shareholders of Strata Critical Medical, Inc. from this filing, though the underlying reason for worthless warrants (stock performance) could be relevant.
• Reporting Person (Velibor Krstic): Experienced a complete loss on the 1,577,500 warrants.

Next Steps

• This filing constitutes the final amendment to the Schedule 13D of the Reporting Person regarding these securities.

Key Dates

Keywords

Strata Critical Medical, Warrants, SRTAW, Schedule 13D, Beneficial Ownership, Expiration, Velibor Krstic, Medical Technology, Investment Loss